Enliven Therapeutics Inc (ELVN)
Operating Cash Flow (Statement)
-$18.53M
Quarterly · Period ending: · USD
ELVN Operating Cash Flow (Statement)
Latest reported-$18.53Mperiod ending
Latest reported-$18.53Mperiod ending
ELVN Quarterly Cash from Operations (-$2.41M → -$18.53M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
ELVN operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -18,531,000 | |
| -19,291,000 | |
| -15,838,000 | |
| -13,279,000 | |
| -17,057,000 | |
| -24,127,000 | |
| -17,203,000 | |
| -12,193,000 | |
| -20,435,000 | |
| -23,361,000 | |
| -12,482,000 | |
| -15,894,000 | |
| -12,049,000 | |
| -20,844,000 | |
| -8,145,000 | |
| -6,447,000 | |
| -7,124,000 | |
| -10,361,000 | |
| -12,485,000 | |
| -10,901,000 | |
| -10,365,000 | |
| -13,020,000 | |
| -8,269,000 | |
| -10,346,000 | |
| -9,256,000 | |
| -9,527,000 | |
| -8,042,000 | |
| -6,280,000 | |
| -5,148,000 | |
| -2,407,000 |